Welcome to BaselArea.swiss

Fostering innovation & accelerating business in Switzerland’s most dynamic economic region >>>>

No. 1 in Swissness

Swissness means business-friendly, reliable and productive. As an economic powerhouse and with decidedly pro-business core values, ... >>>> Swissness means business-friendly, reliable and productive. As an economic powerhouse and with decidedly pro-business core values, the Basel region is a shining example for these Swiss virtues.

No. 1 in Life Sciences and Healthcare

The entire life sciences value chain in one place and easily accessible? That’s what makes the Basel region unique and a preferred ... >>>> The entire life sciences value chain in one place and easily accessible? That’s what makes the Basel region unique and a preferred location for research, development, production and headquarters functions - for 600 companies and counting.

No. 1 in Innovation Industries

Switzerland is considered the most innovative country in the world, according to various studies. Access to knowledge, highly quali... >>>> Switzerland is considered the most innovative country in the world, according to various studies. Access to knowledge, highly qualified and international talent and a strong industrial backbone have turned the Basel region into the leading innovation hub of Switzerland.

No. 1 in Access from and to Europe

Via container ship or by plane: Outstanding connectivity and transportation, bordering Germany and France, and a central location i... >>>> Via container ship or by plane: Outstanding connectivity and transportation, bordering Germany and France, and a central location in the middle of Europe have established the Basel region as a preferred logistics hub and metropolitan platform for international trade.

No. 1 in Culture and Leisure

World-class art treasures, culture and sports events, an international, urban ambience nestled in a healthy natural landscape for r... >>>> World-class art treasures, culture and sports events, an international, urban ambience nestled in a healthy natural landscape for recreation, all of this combined establishes the Basel region as one of the most livable and lively spots to dwell and work in the world.

BaselArea.swiss is a joint initiative for innovation and economic promotion by the cantons of Basel-Stadt, Basel-Landschaft and Jura in Northwestern Switzerland. BaselArea.swiss supports entrepreneurs and companies from abroad with the successful implementation of innovation and business ventures in the Basel region.

Through an extensive network of 15'000 decision-makers, innovators, experts, influencers and multipliers, BaselArea.swiss provides its clients direct access to relevant expertise and specialized know-how.

BaselArea.swiss offers its clients customized services in four main areas:

  • Invest in the Basel Region helps clients with personalized support in deciding where to locate their business activities in the Basel region. Companies can expect competent advice during the entire site selection and settlement process.
  • Connecting Innovators helps connecting companies and researchers in technology, R&D and innovation matters, and within the tech industry sectors Life Sciences, Medical Technologies, ICT, Micro, Nano & Materials, and Production Technologies.
  • Supporting Entrepreneurs offers entrepreneurs, who plan to start a company in the Basel region, overall help and support during the operational implementation of their business plans. Furthermore, start-ups and SME in expansion mode from the technology sectors mentioned above can benefit from strategic networking services to connect with industry experts and investors.
  • Accessing China provides companies in Northwestern Switzerland, which are looking to expand to China with a competent partnering network for a smooth market entry and implementation of their expansion project in China.

BaselArea.swiss also manages a comprehensive information platform, which showcases the competencies and specializations in the Basel business region, and further advances the integration of the region’s innovative players:

  • “Innovation Reports“: Covering the latest stories and reports on innovation in the Basel region and featuring a monthly newsletter with interviews, background stories and news about company settlements in the Basel region.
  •  “Innovation Events“:BaselArea.swiss organizes and co-hosts more than 50 events annually dedicated to knowledge transfer and entrepreneurial culture. “Innovation Events” is where innovators and entrepreneurs share their thoughts and experiences about the latest in innovation.

 

When it comes to competitiveness and the ability to innovate, Switzerland has been one of the world’s top business locations for years. Several factors are responsible for Switzerland’s leading position: In addition to its excellency in education and a state-of-the-art infrastructure, one prominent reason for equating Swissness with business-friendliness, reliability, and productivity certainly is the efficiency of Swiss government authorities. For decades, companies and their investments in Switzerland have been able to benefit from a strong legal system, planning reliability and financial stability. Such an environment also provides the single most important precondition for sustainable expansion into new markets. Not coincidentally, Switzerland can claim the highest density of multinational enterprises.

The Basel region has made major contributions to this Swiss success story. Not only lay the beginnings and origins of numerous leading global players here, their successes also fuels the economic growth of our dynamic region. For instance, GDP numbers for the Basel region are significantly above the national average: The greater agglomeration of Basel achieves the highest gross domestic product per capita. At the same time, the Basel region is boosting Switzerland’s innovative capabilities, largely due to its leadership in life sciences and other high-tech sectors that are strongly represented in the area. For example, roughly a fifth of Switzerland’s value of exported goods is generated in the Basel region – remarkably considering the Basel region represents less than 10% of the Swiss population.

Four eminent features are at the core of the excellent reputation that Switzerland, and the Basel region in particular, enjoy when it comes to global competition of business, industry and knowledge locations:

  • Intelligent tax policies: Federalism as Switzerland’s guiding principle encourages active fiscal competition among cantons - which keeps tax rates within reasonable brackets. Apart from a flat tax rate on a federal level, the cantons are solely responsible for setting the tax rates - and for providing a best possible business environment for companies. As a result, the main beneficiaries of the Basel region are companies active in innovative industries with a high value add, as well as companies investing substantially in research, development and production.
  • Liberal labor market: Given the high density of internationally active high-tech companies in the Basel region, local authorities are supportive in order to answer the demand for highly qualified experts and executives from abroad. Companies also benefit from one of Europe’s most liberal labor market, while simultaneously being able to offer employees great benefits. The Basel region’s labor regulations and market allow companies to react quickly if changes in the business environment require action.
  • Sustainable infrastructure: In Switzerland, 5 minutes of train delay is considered unpleasant and exceptional – which routinely puts a smile on the faces of visitors from other countries. It is a well-known fact that the Swiss public infrastructure is rightly considered one of the most modern and reliable of the world – much to the advantage of companies in the Basel region: Exceptional connectivity by car, train or plane from and to all of Europe – and by waterway on the Rhine to all over the world.
  • Dual education system: Only a third of young Swiss finish high school and continue to earn degrees at one of Switzerland’s top universities. For many other countries this might represent a disastrous educational failure. In Switzerland, it’s actually part of the country’s success of professional formation. The aim of Switzerland’s “dual” education system is that a majority of young people will complete a Swiss-Federation-certified apprenticeship in order to join the workforce early on. A specialization, mostly „on the job“, is possible and often pursued at one of the country’s technical colleges or universities of applied sciences. This provides the Swiss labor market with a steady supply of entry-level employees with several years of on-the-job training and who will flexibly work in the most promising sectors, and where the actual demand is from employers and the industry. In addition and especially in the Basel region, there are many and well-established international schools that address the needs of expats and their kids for easy integration.

Being the only political system based on direct democracy, Switzerland has developed a uniquely cohesive political and social culture over the centuries. It is characterized by federalism, autonomy, and concordance, and has been the foundations of a stable political and social environment and is an embodiment of Swiss values. With its open-mindedness, the pragmatic can-do attitude of its authorities and people, the Basel region is a superb example of a business location that offers companies a great environment in which they’re all but certain to thrive.

The Basel region is one of the most sought-after life sciences locations in the world and clearly Europe’s No. 1. With Roche and Novartis, two out of three global market leaders, hail from the Basel region from where they run their global operations.

Just like them, several other international players have established central business divisions here in Basel, among them Elanco (Eli Lilly Company), Abott and Bayer. A good deal of newcomers such as Actelion, Basilea, Evolva and highly specialized companies like Bachem and Polyphor complete Basel’s life sciences ecosystem. Not surprisingly, the Basel region has also morphed into a hotspot for promising start-ups.

The Basel region is home to a total of 600 life sciences companies that are making a substantial contribution to an already dynamic business environment. Their sustainable success is mainly based on the following three factors:

  • The life sciences industry is the growth engine of the Basel region – home-grown and here to stay: With a total of 27’000 employees in the life sciences sector, the Basel region boasts a production of goods and services worth USD 301 million per hour. This makes the Basel region by far the world’s life sciences destination with the highest productivity. When it comes to gross value, the Basel region is a world champion too: Nowhere in the world are higher production volumes to be found than in the Basel region, with its USD 13 billion p.a. At the same time, Basel’s annually received USD 9 billion investments in research and development makes the region a leader in this discipline too. Local life sciences are responsible for above-average economic growth – a fact reflected in the spotless reputation that the industry enjoys in the Basel region.
  • In the Basel region you’ll find talent and specialists with all kinds of competencies – quite often even in walking distance: From research and start-ups to manufacturing, marketing and distribution you’ll find the complete life sciences value chain of the Basel region practically on-site, and hence a deep talent pool of experienced specialists and experts at every stage and for every function of your company. Add top-of-the-line research institutes like Biozentrum at the University of Basel, the Department of Biosystems Science and Engineering of the ETH Zürich and the Friedrich Miescher Institute, and you’ll begin to grasp the extent of the Basel region’s unique life sciences mix. Its depth and density of resources, expertise and talent – oftentimes literally in walking distance – is unmatched in a global comparison and provides a uniquely fertile ground for innovations of the future.
  • The Basel region is a beacon of innovation in the life sciences – with a long tradition of more than 250 years: The Basel region can rightly claim to be the life sciences location with the longest history. From the beginnings with its industrial silk ribbon dye mills in the mid-century 1800s up to the biotech revolution, the Basel life sciences ecosystem has repeatedly evolved and reinvented itself in the course of the industry’s larger developments. This success story continues to be written. Unlike other historically grown life sciences centers, the Basel region has enjoyed solid and sustainable growth in recent years. And given a planned capital expenditure of 7 billion Swiss Francs for public and private infrastructure projects in the next couple of years, the region’s next growth spurt is just around the corner.

Tradition, a strong industrial backbone, and profound expertise in research and development, as well as in commercialization, have made the Basel region one of the most complete and full-fledged life sciences destinations in the world. You really would be hard pressed to find a region more suitable for efficient, sustainable and successful pre-commercial and commercial project development in the life sciences.

High-tech is the driving economic force in the Basel region and a guarantor of higher-than-average growth. And it will stay this way.  Because a strong industrial backbone, an international business environment that attracts talent and specialists from all over the world, combined with the world-class Swiss educational system have rendered the Basel region an ideal biotope for innovation. Here, companies, in particular from medical technology, ICT, precision mechanics, as well as from chemical industries, will benefit from the following location features:                         

  • The Basel region stands on strong industrial ground in the high-tech sector: 92% of the industrial value added in the canton of Basel-Stadt is created by high-tech companies. Similarly, in the more rural cantons of Basel-Land and Jura, it is well above 70% and hence above the national average of around 60%. And it’s this latter percentage that has lifted Switzerland into the ranks of the most innovative nations in the world.
  • The Basel region is a front-runner in research and development: In Switzerland, the private sector is responsible for 69% of investments in research and development - a rather high ratio in global comparison – and 40% of which are generated in the Basel region, even though it holds only 10% of Switzerland’s population. Five of the 10 Swiss companies with the most patents registered are headquartered in the Basel region: Roche, Novartis, Clariant, Syngenta and Endress+Hauser. That’s why there simply is no other Swiss business location that employs a larger workforce in research and development.
  • The Basel region is globally connected and attracts talents from all over the world: Approximately one out of five in the Basel region’s population of 700’000 hails from abroad; the expat community currently amounts to 36’000. Situated close to the borders of Germany and France, the Basel region also sees a daily influx of 70'000 cross-border commuters from these neighboring countries. It’s hard to think of another business location, where such intense international business dynamics are unfolding in so little space, to form a center of attraction for professionals and specialists from all over the world.
  • World-class science and academic education: In addition to being a strong industrial research and development location, the Basel region is also perfectly positioned within the European world of academia. With its 2'000 professors and 12’000 students, the University of Basel is one of the oldest in Europe and ranks among the top 100 worldwide. Less than a two-hour train ride away are the Federal Institutes of Technology ETH Zurich (which has a life sciences department in Basel) and the EPFL Lausanne, both among the world’s absolute top-notch universities. In total, the Basel region (including its bordering countries) is home to no less than 167 research institutions in a perimeter of a few 100 kilometers. In addition, Switzerland’s dual education system and the University of Applied Sciences in Northwestern Switzerland provide a steady supply of highly trained professionals and skilled specialists.

Studies and surveys rank Switzerland year after year as one of the world’s leading location for innovation. Thanks to its strong industry backbone, a thoroughly international business environment that attracts talent from all over the world, and combined with the Swiss academic and dual education system, Basel has established itself as the innovation hub of Switzerland. The density of its offerings is truly unique: Maximum scientific performance, industry expertise and know-how, and a qualified labor force can be found within walking distance in the Basel region.


As early as during the Roman Empire, the Basel Rhine Port was known as the most southern navigable port in the waterways leading to the North Sea. After the opening of the first – and for many years the only - bridge over the river Rhine between Lake Constance and the North Sea in Basel in the year 1226, the city evolved into an important trade hub. Bordering France and Germany, and favorably situated in the center of Europe, the Basel region has maintained its leading role as the most important transportation and logistics hub of Switzerland – with many benefits for local industries and business in general.
In addition, the Basel region is particularly suitable for companies intending to establish an international headquarters in Europe, and for businesses actively pursuing new opportunities in global trade. The Basel region offers the following unique benefits:

  • The Basel region is an important European traffic hub: A mere 15 minutes by taxi or bus away from downtown Basel, the EuroAirport connects the region directly to more than 90 destinations in Europe, Northern Africa and the Middle East. From the city’s three Rhine ports, containers can reach Rotterdam within three days and be shipped from there all over the world. A train leaves nearly every hour to all major Swiss cities like Zurich (including the Zurich International Airport), Bern, Lausanne and Geneva, as well as economic centers on the river Rhine (i.e. Freiburg, Karlsruhe and Strasbourg). And Europe’s leading metropolitan and capital cities such as Frankfurt, Paris and Milano can be reached easily and conveniently in a few hours on a high-speed train.
  • The Basel region is Switzerland’s leading logistics hub: Basel’s three Rhine ports handle 12% of Switzerland’s foreign trade along with 842'000 tons of food and produce per annum. The entire Basel region processes a third of Switzerland’s foreign trade. Basel’s EuroAirport is Switzerland’s leading airport for freight. This fits the picture of Basel as a logistics hub, with a workforce of more than 23'000 employed in the logistics sector. 990 logistics companies – among them market leaders such as DHL, Panalpina, Goldrand or Kerry Logistics – call the Basel region home. Here, they provide sophisticated solutions for complex challenges, e.g. in supply chain management, that are routinely in demand by companies in the life sciences and the chemicals industry.
  • With its central location in Europe, the Basel region is an ideal location for companies active in international trade: Companies as diverse as Davidoff (specialty tobacco), Dufry (retail), Transgourmet (catering) or BIS (Bank for International Settlements, international finance) underline that goods of all kinds are being traded and provided from Basel. Accordingly, Swiss retail giant Coop (the country’s second largest supermarket chain), and Manor (largest Swiss department store) have chosen to locate their headquarters here. The Basel region is also an important location for an array of international trade fairs and exhibitions. A large portion of the international watch and jewelry industry’s revenue is realized annually at BaselWorld. And ArtBasel simply is the world’s most important art fair. A growing number of international consumer brands have discovered the advantages of Basel as a trade hub and opened European headquarters in the Basel region. Among them are for instance the well-known US lifestyle brand Fossil, bicycle manufacturer Cannondale, or fashion and design label Tally Weijl.

A growing number of global companies is discovering the appeal of the Basel region for opening a global or European headquarters, particularly given the outstanding connectivity and transportation system, and the local competencies in logistics and international trade. Well-established Swiss companies and start-ups alike are taking advantage of this central location within Europe. Last but not least, the vicinity to Germany and France, a thriving exchange with the rest of the world, and the cosmopolitanism of the local population make for a dynamic, continuous and sustainable growth of the entire business region.

Breakfast in Germany, lunch in France and dinner in Switzerland: where three borders meet and brimming with the cosmopolitan flair of global businesses, the Basel region sports an un-paralleled quality of life, at a lower cost than in other metropolitan areas of Switzerland. Award-winning architecture, the historic downtown, and a rich and elaborate cultural life – from hipster to classy – are the pillars of an outstanding urban lifestyle in the Basel region. At the same time, a well-developed public transportation system provides quick and direct access to suburban and rural residential areas along with natural parks and sites for local recreation.

Just ask newcomers and recent arrivals: Not only does the Basel region sport Switzerland’s largest expat community with a comprehensive offer of international schools for their kids. Basel can also claim the largest share of expats that have settled and made their home in the region for longer than 5 years. There’s more than one reason for this:

  • In Basel’s urban lifestyle and rich cultural life there’s something for everyone: The roots of Basel go all the way back to the times of the Romans and the Celts. The region reached its prime for the first time towards the end of the Middle Ages and at the beginning of Modern Age. Of course, Basel didn’t stop there: Today, a thriving creative sector, a variety of restaurants for the local foodie scene, paired with a rich calendar of cultural events all but guarantee a vibrant metropolitan lifestyle. On a stroll through the picturesque historical downtown, during the local carnival season, at a concert in the neo-baroque symphony hall, or simply while enjoying an outdoor movie on the Münsterplatz town square in summer: there is always something going on in Basel.
  • In Basel, art lovers have come to the right place: The Kunstmuseum Basel, founded in 1671, is considered the oldest public community art collection and according to a rating of the Times of London one of the top 5 art museums in the world. By no means a less appealing point of attraction is the Fondation Beyeler museum, which was designed by the Italian star architect Renzo Piano. Another Basel art highlight is the world’s largest art fair, the Art Basel. Every year, artists, collectors, galleries and auctioneers, as well as celebrities and VIPs have their calendars marked for Art Basel. Some of them might even catch one of the many internationally acclaimed and award-winning performances of the Theater Basel (with opera, drama, and ballet).
  • Sports are always happening in the Basel region – and not only at the stadium or on the couch: The best of the best in European football (viz. soccer) competitions are hosted by local favorites FC Basel in their St. Jakob Park home stadium. And the aces of the ATP Tour are serving it up at the Swiss Indoors tennis tournament – including the region’s very own native and superstar Roger Federer. Even outside the arena, the folks of Basel are quite keen on sports: No other Swiss city can claim a higher bicycle use, be it commuters riding to work or recreational cyclists on one of the numerous bike paths in the surrounding country side. Runners find unobstructed tracks along the shores of the river Rhine. Cross-country skiers can glide for miles and miles on the gentle runs in the canton of Jura. And after a short drive of less than two hours, alpine skiers and snowboarders will stand on pristine slopes in the Swiss Alps.
  • Where the borders of Switzerland, Germany and France meet, and an enticing diversity of activities awaits: A wine tasting in Alsace, a gourmet feast in Southern Baden-Württemberg or a cozy picnic on a mountain range in the Jura? In the Basel region there’s hardly a wish that cannot come true in an hour’s drive. And there’s always something new to discover! Ever wanted to jump in a cool river after a hot summer’s day? That’s when the shoreline of the river Rhine turns into a veritable Mediterranean Riviera – in the heart of the city of Basel.

Variety and diversity within short distances, a first-rate public transportation infrastructure like no other, and safety and political stability routinely place Switzerland in the top ranks of the leading quality of living surveys. All of this can easily be found in the Basel region, enriched with a unique mix of arts and culture, lifestyle and an international flair. Not surprisingly, Basel is considered one of Switzerland’s hippest and trendiest places among young Swiss.

Our services
Gabriela Güntherodt

Your contact person

Gabriela Güntherodt

Member of the Management Board, Head of International Markets & Promotion

Contact us

Invest in Basel Region

Is your company in expansion mode? Are you looking into establishing a presence in Europe and Switzerland to break into new markets? Then the Basel region is your location of choice. Within close proximity you’ll find everything you need for long-term and sustainable succeed.

A number of multinationals, first and foremost in life sciences, guarantee for a truly international business environment. The Basel region sports a global-minded talent pool, and a highly skilled workforce across the entire value chain and across functions. Located in the center of Europe and directly neighboring France and Germany, the Basel region offers an outstanding business framework while enjoying Switzerland’s world-renowned quality of life.

Would you like to find out how your company can benefit from establishing a presence in our business location? We’ll gladly show you how. Our specialists advise companies like yours during every stage of their expansion projects, comprehensively and expertly:

  • Evaluation: Taxes? Job market? Competitors? Permits? Industry environment? We compile all the relevant information and data about the Basel region and Switzerland for you, customized to your individual project requirements.
  • Site selection: any open questions? We facilitate contacts to the right experts to answer your questions. We’ll connect you to our government authorities, industry and legal experts, and provide professional support during your real estate search.
  • Site visit: would you like to get to know the Basel region first-hand? We’ll diligently plan your site visit and put together a customized itinerary, with maximum efficiency and fully matched to your requirements.
  • Business development: do you want to accelerate your business growth? We support you in establishing relations to local partners and organizations - accelerating your access to the Basel region’s highly diverse business and innovation ecosystem.                                        

Our services are free of charge to companies that are evaluating the Basel region as a potential business location, and hence will contribute to our dynamic business environment. Being innovative with an open mind for new ideas has a long tradition in the Basel region. We are looking forward to hearing about your business idea and helping you to become successful right from the start.

Gabriela Güntherodt

Your contact person

Gabriela Güntherodt

Member of the Management Board, Head of International Markets & Promotion

Contact us

Connecting Innovators

Connecting Innovators brings together ideas, companies and entrepreneurs. This happens both informally at the specialist events organized by BaselArea.swiss and also formally through the individual support provided by BaselArea.swiss for projects with the procurement of experts, cooperation partners and funding. And here the experts from BaselArea.swiss have a broad network of more than 8000 innovators they can fall back on.

In terms of subject areas, the focus of Connecting Innovators is on five core fields: Life Sciences, Medtech, Information and Communications Technology, Production Technologies and Micro, Nano & Materials. Each of these technology fields is managed by a specialist. In close collaboration with industry, the Technology Field Manager defines the programme of events, acts as contact partner for projects and cultivates partnerships with relevant research groups and other institutions in the Basel region.

Connecting Innovators thus offers the ideal entry point for gaining a foothold in the Basel region and profiting from its diverse innovation ecosystem. Entrepreneurs, innovators and experts get together for regular exchanges of ideas and know-how at more than 50 meetings each year – in a variety of formats:

  • Events: focus on knowledge transfer, offering companies and especially also start-ups the opportunity to present themselves and their projects and promoting regular exchanges of experience and knowledge across companies and disciplines among innovators in the Basel region.
  • Workshops: address a topic in depth by facilitating dialogue within a body of experts that extends across companies and disciplines – with the aim of exploring the spectrum of applications for new technologies and initiating concrete projects and cooperative ventures.
  • Technology & Innovation Circles: are seen as initiatives that run for several years in order to develop an innovation topic further within a community that extends across companies and disciplines and to exploit new market potential.

BaselArea.swiss also offers specific events and services to companies in the founding phase under Supporting Entrepreneurs.

Sebastien Meunier

Your contact person

Sebastien Meunier

Member of the Management Board, Head of Innovation & Entrepreneurship


Tel. +41 61 295 50 15

sebastien.notexisting@nodomain.commeunier@baselarea.notexisting@nodomain.comswiss
Sebastien Meunier

Your contact person

Sebastien Meunier

Member of the Management Board, Head of Innovation & Entrepreneurship

Contact us

Supporting Entrepreneurs

Looking to start a company? That’s great, because our region lives from entrepreneurship. As promoter of innovation and inward investment for the Basel region, BaselArea.swiss provides support especially for entrepreneurs focused on technology and innovation.

At the heart of the service we can offer is our programme of seminars and workshops:

  • Founder Course: The centrepiece of the supporting services on offer is our programme of seminars and workshops: our basic package - the founders’ course - is aimed at all interested parties planning to start a company. You can find an overview of the next courses here: Overview courses

The further range of support on offer is aimed exclusively at start-ups and entrepreneurs with concrete projects from the innovation and technology sector:

  • Seminars & Workshops for Entrepreneurs: These allow a more in-depth examination of various business issues, such as the business plan, funding, product development, pricing and intellectual property, as well as marketing and communications. This series of events is aimed exclusively at start-ups and high-tech SMEs with concrete innovation projects.

In addition to the courses and seminars, BaselArea.swiss also offers individual consultations on concrete projects. The focus here is exclusively on companies and projects with strong growth potential from the field of innovation and technology:

  • Connect & Advisory: In an initial consultation, our expert assesses the need for support and sets up contacts with specialists, research institutions or potential cooperation partners.
  • New Venture Assessment: In a guided process and at individually convened expert meetings, start-ups and innovative SMEs can get their business projects reviewed by established industry experts, entrepreneurs and investors. Further information

With these provide, BaselArea.swiss above all covers the early phase of founding a company. The aim is to valuable information and concrete recommendations between the initial idea and the actual start-up, right through to the first implementation plan and financing round. This not only gives entrepreneurs more security, but also enables them to speed up the implementation of their project quite considerably.

Sebastien Meunier

Your contact person

Sebastien Meunier

Member of the Management Board, Head of Innovation & Entrepreneurship

Contact us
Gabriel Schweizer

Your contact person

Gabriel Schweizer

Senior Project Manager Asia


Tel. +41 61 295 50 13

gabriel.notexisting@nodomain.comschweizer@baselarea.notexisting@nodomain.comswiss

Accessing China

The importance of China as a place for doing business has increased enormously in the past few years – not only as an offshore destination for low-cost production of consumer goods, but also - and increasingly - as a major sales market. The expansion of business into China offers great growth potential especially for small to medium-sized enterprises in the high-tech sector. However, it is not easy to gain a foothold in this complex business area.

BaselArea.swiss therefore offers comprehensive support from a single source to companies in the Basel region (cantons Basel-Stadt, Basel-Land and Jura) – from the initial market evaluation through company trips to concrete procurement of business partners. Besides the necessary expertise, our advisors have excellent local contacts, which have been established over many years of exchanges both on the political and on the business level. BaselArea.swiss also cultivates a large network of companies and experts with experience of China who keep abreast of all the latest developments.

Companies can benefit specifically from the following services:

  • Connect & Advisory: provision of basic knowledge for building business operations in China and individual, case-by-case consulting by experts from Switzerland Global Enterprise.
  • Company and delegation trips: besides the official programme, contacts with potential business partners can also be initiated on an individual basis.
  • Events: deepening exchanges between China and the Basel region with the aim of developing new, shared business potential.

Life sciences companies also benefit from partnerships with the Zhangjiang High-Tech Park and the new Fenglin Life Sciences Park in Shanghai and thus have access to the leading life sciences hub in China. The longstanding team of local partners provides support in both building a business in Shanghai (product registration, funding, marketing and so on) and in establishing contacts with potential business partners and clients.

Gabriel Schweizer

Your contact person

Gabriel Schweizer

Senior Project Manager Asia


Tel. +41 61 295 50 13

gabriel.notexisting@nodomain.comschweizer@baselarea.notexisting@nodomain.comswiss

Our Channels: EVENTS | REPORTS

report Life Sciences

Roivant is making a buzz in Basel

13.06.2017

More than 150 guests were interested in Vivek Ramaswamys approach to the future of health care. The founder of Roivant and five other biotech companies gave a trenchant key note before attending a vivid panel with other representatives of the pharmaceutical and biotech industry. Together, Roivant and BaselArea.swiss had invited stakeholders from the life sciences sector to Halle 7 on Gundeldingerfeld in Basel at June 8th 2017. Roivant just recently settled in Basel with the support of BaselArea.swiss

The audience was eager to hear the key note by the “prodigy” as Forbes magazine called him. What made them so curious? Ramaswamy has a mission: “We concentrate on promising science and passionate people to systematically reduce the time, cost and risk of bringing new medicines to market”, he said. He develops drugs that are shelved by pharma giants that are “stuck” in the middle of the drug development “traffic” within an organization. His means to create an “alternative highway”: bring together the top talent in drug development and other industries to focus on those assets within lean and dynamic structures. Ramaswamy founded not only the mother company Roivant but five additional companies that develop specific drugs in different therapeutic areas: Axovant tackles dementia, Dermavant deals with dermatology, Myovant focuses on women’s health, Urovant concentrates on urology and Enzyvant develops therapies for patients with rare diseases. The companies can tap into standard common capabilities built at Roivant, while the focused companies can develop capabilities of their own to address their own market requirements. Ramaswamy is certain that data will make the difference in bringing drugs speedily to the market.

Settling in Basel without red tape

In his speech, Ramaswamy also made a case for Basel. “Different nationalities are coming together in this place, three different languages are spoken on the street.” Although not big Basel-Stadt and Basel-Landschaft would be “punching way above their weight”. He also mentioned the thriving biotech scene and the deep humanist tradition. He also thanked the Basel authorities for lowering the barriers. “There was no red tape. They made setting up here a pleasure.”

In the following panel, Vas Narashimhan, Global Head of Drug Development and Chief Medical Officer at Novartis, Jonathan Knowles, Chairman of the board of directors at Immunocore Limited, David Hung, CEO of Axovant and Vivek Ramaswamy discussed the future of healthcare. Led by Alethia de Léon from BaseLaunch, the conversation deepened topics like the collection of data. Critical questions about the current challenges and opportunities that pharma is facing were raised. Big Data and biomarkers were some of the highlighted topics as potentially helping address some of the R&D productivity issues the industry is facing.

report Life Sciences

Lonza receives all approvals to acquire Capsugel

27.06.2017

event Life Sciences

Swiss Diagnostics Start-Up Day 2017

Date: 29.06.2017

Place: University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Riggenbachstrasse 16, 4600 Olten

report BaselArea.swiss

BaselArea.swiss got off to a successful start

08.06.2017

In its first annual report, the newly formed BaselArea.swiss can look back on a successful 2016. The joint initiative for innovation and economic promotion by the cantons of Basel-Stadt, Basel-Landschaft and Jura succeeded in growing in all areas. It provided assistance to 36 companies moving to the region, which corresponds to a 50% increase over the previous year. In the area of innovation promotion, over 4,000 participants attended 80 events, expanding the regional network from 8,000 to 13,000 innovators and experts. The services provided by BaselArea.swiss were also actively used to promote start-up projects, contributing to 43 companies being founded.

With a 50% increase over the previous year, the Basel region recorded the biggest growth across Switzerland with the number of new companies to the region. The economic promotion team at BaselArea.swiss advised and assisted 31 foreign and 5 domestic companies relocate to the Basel region. 14 companies came from the US and Europe each, and 3 from Asia. 19 of the new companies to the region are active in the life sciences.

“The consolidation of economic promotion and innovation/start-up promotion under one roof is paying off. By focussing on the strengths of the economic region, the location was able to clearly gain importance as a significant innovation hub in the life sciences and related technologies,” says Christoph Klöpper, CEO of BaselArea.swiss.

Growing network of innovators and experts

BaselArea.swiss succeeded in significantly expanding the network of innovators and experts in 2016, growing from 8,500 people at the end of 2015 to more than 13,000 people at the end of 2016. This puts BaselArea.swiss in a position to better assist clients with respect to relocations as well as innovation and expansion projects by providing them with targeted communication of knowledge and partnerships. The more than 80 events organized by BaselArea.swiss – attended by over 4,000 participants – made a key contribution to the expansion of the network. In addition, BaselArea.swiss supported start-ups and companies in more than 180 individual consultations, including initiating cooperation in research and development as well as in establishing contacts to potential customers and investors. In total, BaselArea.swiss provided assistance that resulted in 43 companies being founded.

BaselArea.swiss grew out of the merger of i-net innovation networks, the economic promotion agency BaselArea and the China Business Platform, and began its operational activities at the beginning of 2016 under the new brand BaselArea.swiss with a unified services portfolio and newly launched website. Its entrepreneurial profile has also been strengthened: industry representatives now form the majority of the Board of Directors, which is chaired by Domenico Scala and is responsible for strategic orientation.

report Life Sciences

Bayer is growing in Basel

26.06.2017

event Production Technologies

3D Printing for Life Sciences

Date: 04.07.2017

Place: FHNW, Gründenstrasse 40, 4132 Muttenz

report BaselArea.swiss

A molecular assembly line to cure the body

08.06.2017

Imagine that certain forms of blindness could be cured. Or imagine that the body itself could produce a cure for some of its own diseases. These may be just some of the results of the National Centre of Competence in Research Molecular Systems Engineering (NCCR MSE). Its long-term goals are to create molecular systems and factories for the production of high added-value chemicals and develop cellular systems for new applications in medical diagnostics, therapy and treatment. Director Thomas Ward is aiming high: He wants to make Basel the leading hub for the next European flagship project. At stake: one billion euro.

Interview: Ralf Dümpelmann

Thomas Ward, you are the director of the NCCR MSE. How did you end up in this position?

Thomas Ward: During my work at the University of Neuchâtel we became curious about artificial metalloenzymes. For instance, we could take ruthenium ion that nature does not have much of at its disposal, and incorporate it in a protein to yield an artificial metalloenzyme. Pursuing this curiosity driven pathway, my group became more and more interested in biological questions. Ultimately I wanted to collaborate with molecular biologists – and this is one of the main reasons why I moved to Basel. When I arrived here nine years ago, the ETH Department of Biosystems Science and Engineering (D-BSSE) had just moved to Basel. That led professor Wolfgang Meier, then head of the Department of Chemistry at our university, to initiate talks with the D-BSSE which were very productive. In the end, he and co-director professor Daniel Müller set out for a National Centre of Competence and Research that ultimately got funded by the Swiss National Science Foundation (SNSF).

What was the goal when starting the NCCR?

Wolfgang Meier and Daniel Müller saw the opportunity to start a collaboration between biologists who relied quite heavily on chemistry and chemists who can provide the required chemical building blocks to address challenging biological questions. This is scientifically a very unique match. In my view this is also reflected in the most important aspect in the title of our NCCR – molecular systems engineering – namely the systems aspect.

Do you build artificial biological systems with the help of chemistry?

At the end of the road, we want to reproduce the properties and the complexity of a living system. There are two ways to get there. The chemical way is to take a compartment, put objects inside one by one and see what evolves. That is the bottom-up approach. On the other hand, a biologist takes a complex system and knocks out components, one at a time. In doing so, biologists focus on computing a system. And they are doing this very well. They can control things, even without fully understanding the molecular details of such systems. These two approaches meet at some point, and that is where our NCCR comes into play.

What could a potential end result look like? A small golem?

If you take the definition of what is life, there are a few features that we are definitely not trying to mimic. We are rather focusing on an artificial organelle, something that you could introduce into a living system and which would work in a living system, but which does not have all the features of a living system itself. I like to call such components molecular prostheses. It is like an artificial Lego block that fits into living systems. There we are already quite advanced.

Can you explain how the work of the NCCR is structured?

The network is planned to work over twelve years, split in three phases. There are roughly 30 groups associated with this NRCC, with some 20 in Basel. When there is somebody outside of Basel who has a competence that we need, they can be integrated to the network. That might be people in the Paul Scherrer Institute or at the University of Bern, for instance.
We are now approaching the end of the first phase of four years. The first step for us as chemists is to synthesise and assemble molecules into modules, an assembly of several molecules. For example, Sven Panke at the D-BSSE and myself synthesise artificial enzymes. Daniel Müller of the D-BSSE on the other hand manipulates pore proteins which allow to control the trafficking of substrates and products in and out of a cell. The goal is assemble an artificial organelle containing two or three enzymes and to introduce this prosthesis inside a cell. With that we can complement the natural metabolism of a cell with an artificial metabolism to produce new chemicals. At the end of the first phase, we ideally want to have solved the module’s problem. In the second and third phase, we can then focus on creating molecular factories and cellular systems.
Ultimately, a chemical factory could produce something that could be useful and a cellular system could be used to cure a disease. For both of these goals, you need a molecular assembly line, much in the spirit of what Henry Ford developed in the early twentieth Century, but at a molecular scale.

Do you already get a stable system out of these assembly lines?

Yes. The question is, however, how stable and for how long. We have systems that function in a cell for two weeks. Whether this is enough to cure a disease remains to be demonstrated.

What benefits may come out of it?

Our aim is to change the way biology and chemistry work in the long term. It is a risky strategy, but with a potentially high payoff.

What would be the high payoff?

You put a molecular or cellular system in the body and it treats or cures a disease.

When will that be feasible?

There are two systems, which are already very well advanced. Both were initiated and funded by the NCCR. Botond Roska of the Friedrich Miescher Institute for Biomedical Research has developed a system that can be injected into the eye to regain vision. This system will enter clinical trials in Winter 2017. It is based on genetic engineering, where you have to inject DNA so that your eye starts to produce pigments again. The other one is aimed at curing diabetes. Your fat cells are re-programmed into cells that are capable of producing insulin. They are then injected into your body and allow you to autonomously produce insulin when the body needs it.

Will these ideas be used in start-ups?

Yes. There are already two start-ups that were created in the past three years. The diabetes treatment is also seriously being looked at for a start-up. The SNSF wants to see things like that. It wants us to bring our research to an advanced stage.

You are organising the International Conference on Molecular Systems Engineering in Basel at the end of August. What is its main goal?

It is a challenge to organise such a conference because people who attend conferences like to talk to specialists in their fields. In our case, we want to apply our approach to a number of different fields. There will be outstanding speakers, but we have to convince people that it is worth looking at the subject from a broader perspective. The good news is that there are similar projects in Europe, in the Netherlands and in Germany. We will have a pre-conference, where graduate students from these other projects can exchange experience and ideas with students from the NCCR.

Is the conference a step to the European level?

Four years ago, the EU funded so called flagship projects. One of them was the Graphene project in Manchester, the other one the Human Brain project at the EPFL in Lausanne. These flagships have a budget of a billion euro. It seems that Europe will have a second round of such flagship projects in a few years. Our aim is to apply for the funding together with our partners in Germany and the Netherlands which would ensure the development of molecular systems engineering at a European level in the future.

In unique events the conference combines art and research. What is the idea behind this special mix?

It is about communication and ethics. We asked ourselves how we can talk about our research as it is quite complex for lay people to understand. One answer is to interact closely with artists and see if they can show their interpretation of what we do, and hopefully this would speak more to the public. We worked with artists hoping that they might rise interest in our research. Furthermore we can engage the public in a dialogue about ethical questions.

When will this dialogue start?

At our conference the argovia philharmonic will present a composition based on illustrations and videos we have provided them with. On the same day, we will also have a public ethics debate. We have brought in an editor of “Science” who will animate the debate and there will be three people debating. We hope one of them will be a bioethics officer of the Pontifical Academy for Life, the two others will be scientists.

What was for you the scientifically most exciting aspect of this NCCR?

When we started, we had a very broad approach and we had quite a number of curiosity-driven research projects. Without it, we would not have come as far as we did in these three years. For the second phase – we have just submitted the pre-proposal – we are much more focused.

What do you hope to achieve at the end of the NCCR?

If we only get one product in use this would already be a very nice achievement. Imagine, for example, that we could say: This NCCR has cured some forms of blindness.

About:
Professor Thomas Ward, born in 1964 in Fribourg, is the director of the NCCR Molecular Systems Engineering. He heads the Ward Group at the Department of Chemistry of the University of Basel. The group’s research focuses on the exploitation of proteins as a host for organometallic moieties with applications in catalysis as well as in nano-biotechnology.
Ward studied organic chemistry at the University of Fribourg. He wrote his PhD thesis at ETH Zurich. He did a first postdoc with Roald Hoffmann at Cornell University in theory and then a second postdoc in Lausanne. He was then awarded an A. Werner Fellowship and moved to Bern where he obtained his habilitation. He moved to Neuchâtel in 2000 and to Basel in 2008. He was awarded a prestigious ERC advanced grant in 2016 and the 2017 Royal Society of Chemistry award in Bioinorganic chemistry.

report Invest in Basel region

Kühne + Nagel celebrates ground-breaking for Pharma Hub

26.06.2017

event Supporting Entrepreneurs

Workshop „Mixed Management Pickles“

Date: 14.07.2017

Place: Startup Academy, Picassoplatz 4, 4052 Basel

report BaselArea.swiss

Investing in strengths – Swiss leadership in life sciences

15.05.2017

How can Switzerland and the Basel region maintain their international leadership role in life sciences? As part of the Biotech and Digitization Day, Federal Councillor Johann Schneider-Ammann visited the Basel region to discuss current trends and challenges with a high-ranking delegation from politics, business, research and start-ups.

The importance of life sciences for the Swiss economy is enormous. Last year, the sector was responsible for 45% of total Swiss exports. Similarly, the majority of new relocations are active in the healthcare sector. Switzerland is said to a leading life sciences location in the world with the Basel region as its engine.

It is against this backdrop that Federal Councillor Johann Schneider-Ammann, head of the Federal Department of Economic Affairs, Education and Research, was invited by BaselArea.swiss and digitalswitzerland to visit the Basel region as part of the Biotech and Digitization Day to discuss current trends and challenges in life sciences with a high-ranking delegation from politics, business and research.

The event was held at Actelion Pharmaceuticals and the Switzerland Innovation Park Basel Area in Allschwil in the canton of Basel-Landschaft. Federal Councillor Schneider-Ammann emphasised the significance of the region and life sciences industry: “The two Basels have a high density of innovation and successful companies, research institutes and universities. This fills me with pride and confidence. Pharmaceuticals and chemistry are rightly regarded as the drivers of innovation.” But Switzerland cannot rest on its laurels if it is to remain successful in the future; business and politics, science and society must all use the digital transformation as an opportunity, he insisted.

The event was organised by BaselArea.swiss, which promotes innovation and business development in the northwest Switzerland cantons of Basel-Stadt, Basel-Landschaft and Jura, and digitalswitzerland, the joint initiative of business, the public sector and science, whose aim is to establish Switzerland as a leading digital innovation location in the world.

Federal Councillor Schneider-Ammann is currently visiting Switzerland’s leading regions to get an impression of the effects of digitalisation on different business sectors and to talk about promising future concepts.

Supporting biotech start-ups

Life sciences are regarded as a cutting-edge sector with considerable growth potential. But competition among the different locations is becoming more aggressive as other regions in the world are investing heavily to promote their location and attract large companies. A central question of today’s event was: How can Switzerland and the Basel region maintain its leadership role in the face of international competition?

Given its major economic importance in life sciences and when measured against other leading locations worldwide, Switzerland has comparatively few start-ups in this industrial sector. With the launch of BaseLaunch, the new accelerator for healthcare start-ups, BaselArea.swiss and the Kickstart Accelerator from digitalswitzerland have taken a first step to changing this. However, in addition to the lack of seed capital in the early phase of a company’s development, there is also a lack of access to the large capital that an established start-up requires in order to expand. Said Domenico Scala, president of BaselArea.swiss and a member of the steering committee of digitalswitzerland: “We have to invest in our strengths. This is why we need initiatives like Swiss Future Fund, which aims to enable institutional investors to finance innovative start-ups.”

The importance of an innovative start-up scene for Switzerland as a centre of life sciences was also a topic for the roundtable discussion that Federal Councillor Schneider-Ammann held with Severin Schwan, CEO of the Roche Group, Jean-Paul Clozel, CEO of Actelion Pharmaceuticals, Andrea Schenker-Wicki, rector of the University of Basel, and others.

Digitalisation as a driver of innovation

The second topic at the Biotech and Digitization Day was digitalisation in life sciences. According to Thomas Weber, a member of the government of the canton of Basel-Landschaft, this is an important driver of innovation for the entire industry and is crucial to strengthening Switzerland as a centre of research.

In his speech, Federal Councillor Schneider-Ammann focused on three aspects: first, the creation of a new and courageous pioneer culture in which entrepreneurship is encouraged and rewarded for those who dare to try something different. Second, more momentum for start-ups by realising an initiative for a privately financed start-up fund. And third, shaping the role of the state as a facilitator that opens up spaces rather than putting up hurdles or bans.

In the public discussion round, in which representatives from research and industry as well as entrepreneurs participated, it became clear that digitalisation is changing life sciences. Everyone agreed that Switzerland has the best conditions to play a leading role in this transformation process. The basis for this are its powerful and globally actively pharmaceutical companies, its world-renowned universities and an innovation-friendly ecosystem with digitally driven start-ups from the healthcare and life sciences fields. 

digitalswitzerland wants to promote this, too. According to Nicolas Bürer, CEO of digitalswitzerland, healthcare and life sciences are key industries to making Switzerland the leading digital innovation location.

A further contribution can be made by the DayOne, the innovation hub for precision medicine. Launched by BaselArea.swiss in close cooperation with the canton of Basel-Stadt, it brings together on a regular basis a growing community of more than 500 experts and innovators in an effort to share ideas and advance projects.

report Life Sciences

Versant Ventures backs Repare Therapeutics

23.06.2017

event Supporting Entrepreneurs

Vorbereitung zur Firmengründung

Date: 24.07.2017

Place: BaselArea.swiss, Dufourstrasse 11, 4052 Basel

report BaselArea.swiss

The healthcare system must take responsibility

09.05.2017

Kristian Schneider wants to improve the quality of health care and better manage the rising healthcare costs by means of a network that includes doctors, hospitals, insurance companies and the state. Its aim is to provide exactly those services needed for the health of patients. For the canton of Jura, which like all other cantons suffers from the fragmentation of service providers, this could be a unique opportunity to build an integrative care system – and thus become a pioneer, says the director of Hôpital du Jura.

Interview: Fabian Käser, Steffen Klatt

What brought you to the canton of Jura?

Kristian Schneider: I was asked and had 16 hours to decide and submit an application in French. The likelihood of ending up in a high-level managerial position as a nurse is relatively rare. There are only three hospitals in Switzerland that are run by people with a nursing degree.

How did your new colleagues react to a nurse becoming a hospital director?

The reactions were almost all positive. Nurses have a different understanding of the system and speak differently with the people who are supposed to produce health – because they have done it themselves.

How are you received as a German?

I have lived a large part of my life in the greater Basel region. The Jura is not far from there. When I was approached by the canton of Jura in 2012, I was living not far from Belfort, just 20 minutes from the Jura border. This creates an affinity. But I hardly knew the canton. I quickly noticed that the people here are very friendly and open. You can build up a network quickly.

How did you approach the work?

I arrived on 1 January 2013, and the budget was already prepared with a loss of CHF 4.5 million predicted. We then created an action plan to overcome the loss, starting 40 projects to increase resource efficiency and flow efficiency. We were fairly successful in the end.

How did people react?

Although we defined the action plan from above, we made an effort to implement it together with our staff. For example, we had too many operation blocks, and our specialists suggested that we concentrate all operation blocks in Delémont. People knew where we are inefficient; we only have to give them permission to change it. But this also requires a cultural shift.

Where do things stand now?

We broke even in 2013. And we’ve been balancing our accounts since then – while the canton is less and less able to be involved in the hospital. We’ve tidied many things up and have done more in certain areas than other hospitals in the French-speaking part of Switzerland. We’ve since come so far in coding cases that we can now make this service available to other hospitals, such as Neuchâtel. With respect to accounting, our accountants have confirmed that we have the highest quality in the French-speaking part of Switzerland. We were the first hospital to be REKOLE-certified (the system of revising cost accounting and assessments in accordance with the requirements of the Health Insurance Act, ed).

We’ve also better positioned ourselves in the canton. We’re in a unique situation here: as a hospital, we have a “quasi monopoly” in acute care, outpatient care, and also in neuro-rehabilitation and geriatrics. We have 28 per cent of nursing home spots. We therefore cover a good deal of health care in the canton of Jura.

What comes next?

Credit Suisse is forecasting that health insurance premiums are set to double by 2030. In the canton of Jura, this would put 60 per cent of the population below the poverty level. So this raises the question of how we can shape health care in a way that we can still pay for it.

What is driving the costs?

Primarily outpatient care and the age structure. Of course, most of these costs are in the final one or two years, but they begin to rise in the years leading up to this. To prevent this, we need a healthcare system with greater efficiency. Many of today’s costs do not contribute to improving health.

How do you plan to manage the cost drivers?

If I see my role as guiding people through a healthy life, then this also means that people consume only as many healthcare services as they need. So I have to prevent doctors from prescribing services that people don’t really need.

The only way to achieve this is by making all actors take responsibility for the quality and the costs. Doctor have to be paid for keeping their patients healthy.

What could this look like?

We have to build up a network in close cooperation with doctors and change the financing system. Let’s assume that every person has a healthcare budget of CHF 5,000 per year, for instance. Then we would have CHF 360 million for the entire canton of Jura with its 72,000 inhabitants. No more. If something is left over, then it would remain in the network and everyone would have an interest in prescribing only that which brings added value. And there would also be an interest in investing in preventative care.

How would you organise this?

You first have to create a network and regulate it through a framework contract. The most important rule is that everyone only does what is actually necessary. In this network you form a quality committee as a second level, which uses actual cases to examine if the cooperation works. Thirdly, the actors should work together in a physical sense as closely as possible. So if I build a hospital, a healthcare centre should be built right next door to it. And fourthly, the network must invest in preventative care. This can also be because money is left over.

How would you finance the network?

This would be done by the insurance companies. They have no interest in having us exhaust the maximum budget. Insurance companies would therefore sell the model to their policyholders. Insured people who decide in favour of our network would then pay somewhat less than if they had a completely open choice of doctor and hospital.

Isn’t this what Swica is already doing with its healthcare centres?                                                                                              

Swica only does this with primary care, without a hospital. The canton of Jura now has a unique opportunity: it is manageable and has only one hospital

What do you need to build this network?

I would need an experienced partner. And it already exists: Réseau DELTA is a network in the greater Geneva area that is active in primary care. It is very interested in trying something like this with a hospital. We are also talking with Medbase and University Hospital Basel as potential partners. In the end it also needs the canton because the financing model will be changed. But I don’t see a problem there.

Because it will be the same amount just under a new name for the canton?

Precisely. The 55 per cent, which it assumes for hospital accommodation, could be part of the overall budget. It could then show its citizens that healthcare costs no longer have to automatically increase. At least not for those who choose our network model.

When do you begin?

I’m already negotiating now. For the first time since it was founded, the canton is now writing its owner strategy. It has to explain if it has expectations of us as a hospital in regard to the overall costs of the healthcare system. And if yes, if we have the freedom to change the structures. The federal government, which is ultimately responsible for the financing, is open to such models. The canton of Jura could therefore take a step toward a completely different system. It could even establish itself as a region where well-off elderly people spend their last years. This could turn health care into an interesting economic factor in the Jura.

Will you stay in the canton of Jura until you retire?

Enjoying my work matters to me, and I have that here. But I’m unsure if this would also be good for the hospital. Only time will tell. In our past-paced world we need change at such positions, fresh impetus.

About:

Kristian Schneider (45) was born in Frankfurt am Main. He was trained as a nurse in Basel and worked for close to 20 years at University Hospital Basel, the last five years as head of the emergency department. From 2007 to 2009 he completed a diploma programme at the University of Bern in Health Care Management. He has been the director of Hôpital du Jura since 2013. The Jura Cantonal Hospital was formed in 2002 through the merger of the hospitals in Delémont, Porrentruy and Saignelégier and employs 1,655 people.

report Life Sciences

Clariant opens smart greenhouse

22.06.2017

event Supporting Entrepreneurs

Workshop Business Model Canvas

Date: 19.08.2017

Place: Startup Academy, Picassoplatz 4, 4052 Basel

report Invest in Basel region

Basel-Landschaft welcomes new companies

21.04.2017

The canton of Basel-Landschaft welcomed a host of new companies over the past few weeks. BaselArea.swiss played in a big role in attracting the companies to establish themselves in Basel.

The companies now represented in Basel-Landschaft are from a variety of different sectors – some work in the sales of medical technology products, others in the manufacture of diagnostic tests. Also newly established in the canton are a music company, a creative agency and a provider of presentation items. BaselArea.swiss consulted these companies and supported them with their establishment.

Medi-CENT Innovation AG, which has offices in Liestal, distributes medical technology products. The company focuses on repairing probes and provides its customers with rental probes in the meantime. Other key areas for Medi-Cent Innovation AG include pain therapy and bone density measurement. Another company now represented in the canton is Predemtec AG. From its location in Binningen, it develops diagnostic tests that can determine the risk factors for dementia.

Musik Hug has opened a new musical world in Allschwil, where it offers a wide range of musical instruments. Its new location also comprises a piano and wind instrument workshop. Newly established in the Dreispitz area is the creative agency MJM.CC AG, which specialises in the production of awards ceremonies, such as the Swiss Film Award and Best of Swiss Web.

Meanwhile, Achilles Präsentationsobjekte GmbH is heading the business of KMC Karl Meyer AG. Thanks to this transition, existing customers can continue to access the consultancy and service portfolio they were accustomed to from KMC Karl Meyer AG. However, they can also access one of the biggest selections of folder and presentation systems in Europe.

report Invest in Basel region

Switzerland is the world’s most innovative country

20.06.2017

event Production Technologies

Production Technology Circle Industrie 4.0 „Mein Unternehmen in 10 Jahren“

Date: 23.08.2017